Kineta News

Kineta | EFFECT: Others

Nov 15, 2023 00:15 ET

Kineta | 424B3: Prospectus

Nov 13, 2023 17:28 ET

Kineta | 424B5: Prospectus

Oct 5, 2023 10:47 ET

Kineta | EFFECT: Others

Jun 13, 2023 00:15 ET

Kineta | 424B3: Prospectus

Jun 12, 2023 17:01 ET

Kineta | 424B5: Prospectus

Apr 21, 2023 17:14 ET

Kineta | 424B5: Prospectus

Apr 20, 2023 08:09 ET

Kineta | EFFECT: Others

Feb 14, 2023 00:15 ET

Kineta | 424B5: Prospectus

Feb 10, 2023 16:48 ET

Kineta | EFFECT: Others

Jan 31, 2023 00:15 ET

Kineta | 424B4: Prospectus

Jan 30, 2023 17:02 ET

Yumanity Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Dec 6, 2022 16:04 ET

Yumanity Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Dec 5, 2022 09:28 ET

Yumanity Therapeutics | 424B3: Prospectus

Dec 5, 2022 09:22 ET

Yumanity Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Dec 1, 2022 16:04 ET

Yumanity Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 29, 2022 16:03 ET

Yumanity Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 28, 2022 16:03 ET

Yumanity Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 15, 2022 16:03 ET

Yumanity Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 14, 2022 08:50 ET

Yumanity Therapeutics | EFFECT: Others

Nov 14, 2022 00:15 ET